8-K
Current Report
Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-018935
Agreement ended · Acquisition or sale completed · Exit or restructuring costs · Impairment · Shareholder rights changed · Change in control · Bylaws or fiscal year change · Regulation FD disclosure
- Item 1.02 Termination of a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.05 Costs associated with exit or disposal activities
- Item 2.06 Material impairments
- Item 3.03 Material modification to rights of security holders
- Item 5.01 Changes in control of the registrant
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading form8-k.htm…